FIGS (FIGS) Q3 2026 Earnings Call Transcript

FIGS reported Q3 2026 revenue of $190.7 million, up 25.7% year over year and ahead of its approximately 20% outlook; adjusted EBITDA margin expanded 410 basis points to 16.5%. Management raised full-year revenue growth guidance to approximately 23.5% from 20% and adjusted EBITDA margin guidance to approximately 15.8% from 14.8%–15%. Gross margin was 69.3%, down 60 basis points, while inventory fell 20% to $121.3 million amid the supplier transition from Jordan; management said the disruption will weigh most heavily in Q4, and the roughly 250-basis-point 2026 tariff-refund benefit will be a year-over-year gross-margin headwind in 2027.

Analysis

FIGS’s demand signal is stronger than reported sales, but the near-term constraint cuts both ways: constrained inventory may defer revenue into 2027, while repeated stockouts risk customer churn if core sizes and limited editions remain unavailable. The key test is whether Vietnam capacity and Indonesia production restore in-stock rates without persistent expediting and higher unit costs. Competitor store closures may create share opportunity, but FIGS’s digital growth does not yet prove that additional physical locations earn attractive returns at scale.

The earnings-quality question is whether operating leverage survives once one-time tariff refunds roll off. Management’s estimated 250bp 2026 refund benefit creates a tough gross-margin comparison; it should not be confused with deterioration in underlying pricing or product economics. Conversely, current margin expansion partly reflects revenue leverage and lower marketing as a share of sales—neither should be extrapolated without evidence. TEAMS and international growth diversify channels, but larger institutional deals bring longer sales cycles and could create fulfillment complexity.

Near term, the result supports the demand thesis, though an immediate rally may already price in raised guidance. Over 1–3 months, holiday sell-through and Q4 stock availability are the catalysts. Over 6–18 months, supplier diversification, repeat purchasing, and TEAMS execution determine whether growth converts to durable earnings. Contrarian risk: stockouts are not automatically deferred sales; poor availability can damage retention, while a 2027 margin reset could disappoint investors focused on 2026 adjusted margins.

Key Decisions for Investors

• Favor a measured long FIGS position, adding on post-earnings weakness rather than chasing strength. The upside case is sustained customer growth with supply recovery; the principal downside is demand normalization or a margin reset as tariff benefits lapse.
• Treat Q4 and early-2027 inventory availability as the key confirmation signal. Track core in-stock rates, sell-through, and whether management still cites stockouts; persistent constraints into Q1 would weaken the deferred-sales thesis.
• For the next earnings review, separate underlying gross margin from tariff-refund benefits and monitor freight, supplier-transition costs, discounting, and returns. A material deterioration in these measures would falsify the margin-resilience case.
• Keep the EWCZ partnership in watch status, not as a standalone long thesis: the disclosed relationship does not establish material revenue or earnings contribution for European Wax Center.